These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 20119648)
1. Olfactory dysfunction and cardiovascular dysautonomia in Parkinson's disease. Oka H; Toyoda C; Yogo M; Mochio S J Neurol; 2010 Jun; 257(6):969-76. PubMed ID: 20119648 [TBL] [Abstract][Full Text] [Related]
2. Olfactory function combined with morphology distinguishes Parkinson's disease. Sengoku R; Matsushima S; Bono K; Sakuta K; Yamazaki M; Miyagawa S; Komatsu T; Mitsumura H; Kono Y; Kamiyama T; Ito K; Mochio S; Iguchi Y Parkinsonism Relat Disord; 2015 Jul; 21(7):771-7. PubMed ID: 25986741 [TBL] [Abstract][Full Text] [Related]
3. Hyposmia and cardiovascular dysautonomia correlatively appear in early-stage Parkinson's disease. Mizutani Y; Nakamura T; Okada A; Suzuki J; Watanabe H; Hirayama M; Sobue G Parkinsonism Relat Disord; 2014 May; 20(5):520-4. PubMed ID: 24637128 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular dysautonomia in de novo Parkinson's disease without orthostatic hypotension. Oka H; Toyoda C; Yogo M; Mochio S Eur J Neurol; 2011 Feb; 18(2):286-292. PubMed ID: 20602633 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of orthostatic hypotension in Parkinson's disease. Oka H; Yoshioka M; Onouchi K; Morita M; Mochio S; Suzuki M; Hirai T; Ito Y; Inoue K Brain; 2007 Sep; 130(Pt 9):2425-32. PubMed ID: 17673498 [TBL] [Abstract][Full Text] [Related]
6. Relationship and factor structure in multisystem neurodegeneration in Parkinson's disease. Hattori T; Orimo S; Hallett M; Wu T; Inaba A; Azuma R; Mizusawa H Acta Neurol Scand; 2014 Dec; 130(6):347-53. PubMed ID: 25209841 [TBL] [Abstract][Full Text] [Related]
7. Cardiac sympathetic degeneration correlates with olfactory function in Parkinson's disease. Iijima M; Osawa M; Momose M; Kobayakawa T; Saito S; Iwata M; Uchiyama S Mov Disord; 2010 Jul; 25(9):1143-9. PubMed ID: 20131383 [TBL] [Abstract][Full Text] [Related]
8. Autonomic Function Tests and MIBG in Parkinson's Disease: Correlation to Disease Duration and Motor Symptoms. Rocchi C; Pierantozzi M; Galati S; Chiaravalloti A; Pisani V; Prosperetti C; Lauretti B; Stampanoni Bassi M; Olivola E; Schillaci O; Stefani A CNS Neurosci Ther; 2015 Sep; 21(9):727-32. PubMed ID: 26205884 [TBL] [Abstract][Full Text] [Related]
9. Cardiac parasympathetic dysfunction in the early phase of Parkinson's disease. Suzuki M; Nakamura T; Hirayama M; Ueda M; Katsuno M; Sobue G J Neurol; 2017 Feb; 264(2):333-340. PubMed ID: 27900499 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular dysfunction in untreated Parkinson's disease: A multi-modality assessment. Strano S; Fanciulli A; Rizzo M; Marinelli P; Palange P; Tiple D; De Vincentis G; Calcagnini G; Censi F; Meco G; Colosimo C J Neurol Sci; 2016 Nov; 370():251-255. PubMed ID: 27772769 [TBL] [Abstract][Full Text] [Related]
11. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver]. Oka H; Yoshioka M; Morita M; Mochio S; Inoue K Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397 [TBL] [Abstract][Full Text] [Related]
12. Olfactory dysfunction and parasympathetic dysautonomia in Parkinson's disease. Kang P; Kloke J; Jain S Clin Auton Res; 2012 Aug; 22(4):161-6. PubMed ID: 22314778 [TBL] [Abstract][Full Text] [Related]
13. Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in de novo Parkinson's disease. Oka H; Toyoda C; Yogo M; Mochio S J Neural Transm (Vienna); 2011 Sep; 118(9):1323-7. PubMed ID: 21331459 [TBL] [Abstract][Full Text] [Related]
14. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. Takatsu H; Nishida H; Matsuo H; Watanabe S; Nagashima K; Wada H; Noda T; Nishigaki K; Fujiwara H J Nucl Med; 2000 Jan; 41(1):71-7. PubMed ID: 10647607 [TBL] [Abstract][Full Text] [Related]
15. Normal 'heart' in Parkinson's disease: is this a distinct clinical phenotype? Kim JS; Park HE; Park IS; Oh YS; Ryu DW; Song IU; Jung YA; Yoo IR; Choi HS; Lee PH; Lee KS Eur J Neurol; 2017 Feb; 24(2):349-356. PubMed ID: 27888574 [TBL] [Abstract][Full Text] [Related]
16. Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease. Izawa MO; Miwa H; Kajimoto Y; Kondo T Eur J Neurol; 2012 Mar; 19(3):411-6. PubMed ID: 21978091 [TBL] [Abstract][Full Text] [Related]
17. Comparisons of cardiovascular dysautonomia and cognitive impairment between de novo Parkinson's disease and de novo dementia with Lewy bodies. Oka H; Umehara T; Nakahara A; Matsuno H BMC Neurol; 2020 Sep; 20(1):350. PubMed ID: 32948137 [TBL] [Abstract][Full Text] [Related]
18. Body weight and dysautonomia in early Parkinson's disease. Umehara T; Nakahara A; Matsuno H; Toyoda C; Oka H Acta Neurol Scand; 2017 May; 135(5):560-567. PubMed ID: 27357472 [TBL] [Abstract][Full Text] [Related]
19. Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy. Lee PH; Yeo SH; Kim HJ; Youm HY Mov Disord; 2006 Nov; 21(11):1975-7. PubMed ID: 16960860 [TBL] [Abstract][Full Text] [Related]
20. Differentiating Parkinson's disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test. Kikuchi A; Baba T; Hasegawa T; Sugeno N; Konno M; Takeda A Parkinsonism Relat Disord; 2011 Nov; 17(9):698-700. PubMed ID: 21840242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]